Trials / Unknown
UnknownNCT04903405
Immune Function Monitoring and Immunotherapy in Sepsis
Immune Function Monitoring and Immunotherapy in Sepsis: a Cross-sectional Survey in China
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
At present, the clinical studies of various anti-inflammatory drugs and immune-enhancing drugs show that immunotherapy will bring new hope for the treatment of sepsis. In order to further understand the current status of immunotherapy in China, this study aims to understand the current status and standardization of the use of sepsis immunosurveillance and immunotherapy in hospitals through a cross-sectional survey.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention is involved in this study |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2021-06-30
- Completion
- 2021-07-30
- First posted
- 2021-05-26
- Last updated
- 2021-05-26
Source: ClinicalTrials.gov record NCT04903405. Inclusion in this directory is not an endorsement.